MedTrace Logo

Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section

NCT02141321 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2015-03-18

No results posted yet for this study

Summary

The aim of the work is to evaluate the efficacy of the sub lingual prostaglandin E1 synthetic analogue (misoprostol) before IUD insertion to facilitate the procedure in patients delivered before only by cesarean section.

Conditions

  • IUD Insertion

Interventions

DRUG

Misoprostol

DRUG

Placebo

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohamed S. Sweed, MD · Ain Shams University

  • Hassan A. Bayoumy, Professor · Ain Shams University

  • Mohamed Y. Mohamed, M.B., B.Ch. · Assiut University

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02141321 on ClinicalTrials.gov